Evogene Schedules Fourth Quarter and Full Year 2022 Financial Results Release & Conference Call for March 9, 2023
28 February 2023, Israel: Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development announced today
Read More